Details of the Drug Reposition

General Information of This Drug (ID: DMLBMU3)

• Drug Name: LLG783 (DMLBMU3)

Information on Drug Reposition of This Drug

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Intermittent claudication	DISGY3B0	BD40.00	Phase 2	[1]
Vascular systems peripheral arterial disorder	DISDI1VW	BD5Z	Phase 2	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)